April 1, 2026: Patient Form Temporary Outage Notice – Patient forms will be unavailable tonight from 9:00 PM – 5:00 AM EST due to scheduled maintenance. Access will be restored on April 2, 2026, by 6:00 AM EST. Thank you for your patience.

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

October 16, 2023

Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » Clinical Trials Search » Investigational Inhibitor of Active RAS Shows Clinical Promise – Alexander I. Spira, MD, PhD, FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise – The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C

Alexander I Spira MD, PhD, FACP, FASCO

Medical Oncologist

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More

Return to Top

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

October 16, 2023

Recent Posts

Weather Advisory: Monday, March 16, 2026

March 16, 2026

New OncoTalks Episode: Advancing Biomarker Testing in NSCLC - Dr. Alexander I. Spira, MD, PhD, FACP, FASCO

February 9, 2026

For the Third Consecutive Year, Virginia Cancer Specialists Named #1 Practice in Virginia for Cancer Care, and Ranked #1 Across All Medical Specialties

February 5, 2026

32 Virginia Cancer Specialists Physicians Named Among NorthernVirginia Magazine’s 2026 Top Doctors for Excellence in Personalized Cancer Care

January 28, 2026

WEATHER ALERT: February 22 - 6:00 PM

January 25, 2026

Award Winning Physicians